Aptahem AB (publ) (NGM:APTA)
0.8560
-0.0280 (-3.17%)
At close: Feb 3, 2026
Aptahem AB Market Cap
Aptahem AB has a market cap or net worth of 18.75 million as of February 5, 2026. Its market cap has increased by 28.74% in one year.
Market Cap
18.75M
Enterprise Value
18.47M
Revenue
2.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.86
Market Cap Chart
Since April 17, 2015, Aptahem AB's market cap has decreased from 51.10M to 18.75M, a decrease of -63.31%. That is a compound annual growth rate of -8.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 18.75M | -21.92% |
| Dec 30, 2025 | 24.01M | 35.28% |
| Dec 30, 2024 | 17.75M | -4.71% |
| Dec 29, 2023 | 18.63M | -73.52% |
| Dec 30, 2022 | 70.35M | -20.14% |
| Dec 30, 2021 | 88.10M | -5.79% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 2cureX AB | 54.72M |
| Pila Pharma AB | 49.66M |
| AcouSort AB | 48.04M |
| Modus Therapeutics Holding AB | 43.30M |
| Guard Therapeutics International AB | 41.14M |
| Nanologica AB | 35.52M |
| NanoEcho AB | 29.18M |
| Novakand Pharma AB | 13.84M |